TOMMASINI, Silvana
 Distribuzione geografica
Continente #
NA - Nord America 5.580
EU - Europa 3.748
AS - Asia 2.775
SA - Sud America 1.181
AF - Africa 102
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.400
Nazione #
US - Stati Uniti d'America 5.503
BR - Brasile 1.070
IE - Irlanda 1.008
SG - Singapore 1.004
SE - Svezia 850
CN - Cina 830
UA - Ucraina 496
HK - Hong Kong 437
DE - Germania 401
FI - Finlandia 233
GB - Regno Unito 224
IT - Italia 205
VN - Vietnam 173
IN - India 92
PL - Polonia 72
AT - Austria 60
FR - Francia 48
RU - Federazione Russa 45
CA - Canada 38
TR - Turchia 35
AR - Argentina 32
MX - Messico 28
IQ - Iraq 26
ZA - Sudafrica 26
BD - Bangladesh 24
CI - Costa d'Avorio 24
EC - Ecuador 21
MA - Marocco 21
UZ - Uzbekistan 19
BE - Belgio 18
JP - Giappone 18
VE - Venezuela 18
CZ - Repubblica Ceca 17
ES - Italia 17
IR - Iran 16
ID - Indonesia 14
NL - Olanda 13
PK - Pakistan 13
AZ - Azerbaigian 11
TN - Tunisia 11
CL - Cile 9
CO - Colombia 9
KE - Kenya 9
IL - Israele 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
PE - Perù 7
PY - Paraguay 7
OM - Oman 6
LT - Lituania 5
LV - Lettonia 5
RS - Serbia 5
EG - Egitto 4
EU - Europa 4
JM - Giamaica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MY - Malesia 4
NP - Nepal 4
AL - Albania 3
DZ - Algeria 3
JO - Giordania 3
KR - Corea 3
NO - Norvegia 3
PS - Palestinian Territory 3
RO - Romania 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
GE - Georgia 2
GR - Grecia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
SV - El Salvador 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.400
Città #
Dublin 1.008
Jacksonville 946
Chandler 659
Ashburn 510
Nyköping 502
Dallas 465
Hong Kong 436
Singapore 404
Beijing 345
Dearborn 203
Princeton 166
Cambridge 161
Medford 152
Los Angeles 145
Dong Ket 140
Des Moines 123
Boardman 109
The Dalles 106
Messina 84
Ann Arbor 83
Buffalo 79
São Paulo 75
Lancaster 69
New York 66
Warsaw 64
Jinan 58
Vienna 57
Munich 54
Woodbridge 51
Wilmington 49
Turku 42
San Mateo 41
Shenyang 40
Pune 37
Tianjin 36
Redondo Beach 35
Rio de Janeiro 33
Helsinki 29
Belo Horizonte 28
Hangzhou 27
Brasília 26
Nanjing 26
Abidjan 24
Augusta 24
Brooklyn 21
Bremen 20
Nanchang 20
Haikou 19
Houston 19
Montreal 19
Brussels 18
Campinas 18
Leawood 18
Tashkent 18
Tokyo 17
Chennai 16
Frankfurt am Main 16
Johannesburg 16
London 15
Boston 14
Curitiba 14
Hebei 14
Porto Alegre 14
Zhengzhou 14
Brno 13
Denver 13
Phoenix 13
Poplar 13
Atlanta 12
Ningbo 12
Salvador 12
Seattle 12
Stockholm 12
Ardabil 11
Baku 11
Ho Chi Minh City 11
Santa Clara 11
Ankara 10
Guangzhou 10
Manaus 10
Nuremberg 10
Bexley 9
Edinburgh 9
Guarulhos 9
Hyderabad 9
Mumbai 9
Nairobi 9
San Francisco 9
Taiyuan 9
Taizhou 9
Auburn Hills 8
Baghdad 8
Casablanca 8
Chicago 8
Dhaka 8
Fortaleza 8
Fuzhou 8
Jiaxing 8
Montevideo 8
Norwalk 8
Totale 8.514
Nome #
{ [1.1.1.] CRYPTAND/THYMOL BLUE } : A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES 200
Analysis of the thermal fluctuations in inclusion complexes of genistein with β-cyclodextrin derivatives 173
{[1.1.1.]CRYPTAND/THYMOL BLUE}: A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES ON PH-RATE PROFILE OF DRUGS 168
Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue neuroprotective effect 138
Anticonvulsant agent: enhancement of physicochemical properties 131
Isoflavone Aglycons-Sulfobutil Ether-beta-Cyclodextrin Inclusion Complexes: in Solution and Solid State Studies 126
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 123
CHITOSAN/SULFOBUTHYL ETHER BETA-CYCLODEXTRIN NANOPARTICLES FOR IDEBENONE DELIVERY 123
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate 119
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 118
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 117
A characterization study of resveratrol/sulfobutylether-b-cyclodextrin inclusion complex andin vitro anticancer activity 117
DETERMINATION OF FLAVONOIDS BY TURBIDIMETRIC MEASUREMETS 115
Acyclovir-b-cyclodextrin prodrugs: an in vitro evaluation for oral administration”. 113
CARATTERIZZAZIONE DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE MEDIANTE:DSC,RAGGI X,DRIFT,UV-VIS 112
Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin 111
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 110
Analytical profile and release of lonidamine from pharmaceutical formulation 110
Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources 110
PLGA/AMPHIPHILIC CYCLODEXTRIN NANOPARTICLES LOADING METHYLENE BLUE FOR NOSE-TO-BRAIN TARGETING IN ALZHEIMER'S DISEASE 109
CORDIA FRANCISCI, C, MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES AS NEW SOURCES OF RUTIN: ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY. 108
Nanotherapeutics for anti-inflammatory delivery 107
SPETTRI DI RIFLESSIONE DI FLAVONOIDI DEDOTTI MEDIANTE TRASFORMATA DI KUBELKA-MUNK . 105
A STUDY OF THE INCLUSION COMPLEX OF ATENOLOL WITH BETA-CYCLODEXTRIN 105
COMBINED EFFECT OF pH AND CYCLODEXTRINS ON SOLUBILIZATION OF NARINGENIN 105
“Host-guest” interactions in Captisol®/Coumestrol inclusion complex: UV-vis, FTIR-ATR and Raman studies 105
Chitosan-Hyaluronan Nanoparticles for Vinblastine Sulfate Delivery: Characterization and Internalization Studies on K-562 Cells 104
COMPARATIVE PHOTODEGRADATION STUDIES: INFLUENCE OF DIFFERENT MEDIA AND LIGHT SOURCES 104
Chitosan nanospheres containing cyclodextrins for idebenone delivery 104
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES. 103
Amphiphilic beta-cyclodextrin nanoparticles encapsulating a carotenoid for drug delivery 103
Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases 101
REAZIONI UV-INDOTTE:FOTOCHIMICA DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE. Nota II 101
B-Cyclodextrin conjugates for sustained release of drugs 100
AN EXPERIMENTAL DESIGN METHODOLOGY APPLIED TO THE CHIRAL SEPARATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG CANDIDATE 99
Photochemistry of flavonoids. Solvent effect on photochemical behaviour of 3-hydroxyflavone. 99
CHROMATOGRAPHIC INVESTIGATIONS ON BROTIZOLAM 99
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 98
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation 97
CONFORMATIONAL SEARCH OF PHENYL SUBSTITUTED GAMMA-LACTAMIC DERIVATIVES. 97
Rutin-Loaded Solid Lipid Nanoparticles: Characterization and In Vitro Evaluation 96
METHODS FOR PARTICLE SIZE DETERMINATION IN POWDERS OF PHARMACEUTICAL INTEREST. Nota II 95
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice 95
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 94
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 93
Celecoxib-loaded PLGA/cyclodextrin microspheres: Characterization and evaluation of anti-inflammatory activity on human chondrocyte cultures 93
Gemcitabine-Loaded Chitosan Microspheres For Local Delivery In Lung, 92
Preparation, characteristics and biological evaluation of micro and nanostructured carriers for controlled release 92
RUTIN INCLUSION SYSTEMS WITH ALFA AND BETA-CYCLODEXTRINS: CIRCULAR DICHROISM, UV ABSORPTION SPECTROSCOPY AND ANTIOXIDANT ACTIVITY STUDIES 90
TECNICHE CHEMOMETRICHE PER L'OTTIMIZZAZIONE DI METODOLOGIE STRUMENTALI IN ANALISI FARMACEUTICA 89
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 89
BETA-CYCLODEXTRIN CONJUGATES FOR SUSTAINED RELEASE OF DRUGS 89
Determination of fludarabine in a pharmaceutical formulation by LC 89
CHIRAL RECOGNITION AND COMPLEXATION BEHAVIOUR OF BETA-CD vs. L- AND D,L-SERINE BY FTIR-ATR SPECTROSCOPY 89
MOLECULAR MODELING OF ENANTIOSELECTIVE RECOGNITION BETWEEN GAMMA-LACTAMIC DERIVATIVES AND CHIRALCEL OD CHIRAL STATIONARY PHASE. 88
CORDIA FRANCISCI, C. MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES: A NEW SOURCES OF RUTIN. ANALGESIC AND ANTIINFLAMMATORY ACTIVITY 88
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays 88
ANTIINFLAMMATORY ACTIVITY OF PLANTS IN TRADITIONAL MEDICINE: CORDIA MYXA L., C. FRANCISCI TEN., C. SERRATIFOLIA H.B.K. 88
UV-INDUCED REACTIONS:EFFECTS OF MICROENVIROMENT ON FLAVONOIDS PHOTOCHEMISTRY 87
INCLUSION COMPLEXES OF SOME FLAVANONES AND THEIR GLYCOSIDES WITH MODIFIED BETA-CYLODEXTRINS 86
DIRECT ENANTIOMERIC SEPARATION OF REBOXETINE BY LIQUID CHROMATOGRAPHY USING DIFFERENT CELLULOSE AND AMYLOSE BASED CHIRAL STATIONARY PHASES 85
Temperature-dependent dynamical evolution in coum/sbe-β-cd inclusion complexes revealed by two-dimensional ftir correlation spectroscopy (2d-cos) 85
Biodegradable microparticles as carrier for moxifloxacine 84
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 84
HPLC DIASTEREO ED ENANTIOSELETTIVA DI 2-ARIL-4-TIAZOLIDINONI SOSTITUITI. 84
METAL-COMPLEXES OF BENZODIAZEPINES . PART 2. THE REACTION OF 1,4- BENZODIAZEPINES WITH HALIDE-BRIDGED COMPLEXES OF PALLADIUM(II) [PD2X4(PPRN3)2] (X = CL OR I) 83
Effects of alpha and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones 82
BIODEGRADABLE MICROSPHERES FOR INTRAARTICULAR ADMINISTRATION OF CELECOXIB 81
GEMCITABINE-LOADED CHITOSAN MICROSPHERES FOR LOCAL DELIVERY IN LUNG 81
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin 80
Solid-state study of polymorphic drugs: carbamazepine 79
HPLC-DAD AND TLC OF FLAVONOIDS FROM LEAF EXTRACTIVES OF GENUS CORDIA. 78
Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation 78
STRUCTURAL AND CONFORMATIONAL STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN COMPLEXES 77
RISOLUZIONE ENANTIOMERICA DI GAMMA-LATTAMI MEDIANTE HPLC. 77
Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation 76
FLUORIMETRIC STUDY OF b-BLOCKERS/b-CYCLODEXTRINS INCLUSION COMPLEXES 76
IMPROVEMENT OF FLAVONOIDS DISSOLUTION PROPERTIES BY COMPLEXATION WITH BETA-CYCLODEXTRIN 76
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 76
Selective reversed-phase liquid chromatography method for the kinetic investigation of 3-hydroxyflavone photostability 76
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 75
Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin 75
MOXIFLOXACIN-LOADED CHITOSAN MICROSPHERES FOR INTRAPULMONARY ADMINISTRATION 74
THE COORDINATION CHEMISTRY OF 1,4 BENZODIAZEPINES.HEAVY METAL COMPLEXES OF PSYCOTHERAPEUTIC DRUGS. 74
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 74
METODI PER LA VALUTAZIONE DIMENSIONALE DI PARTICELLE DI POLVERI DI IMPIEGO FARMACEUTICO.Nota IV. 74
VALIDATION OF A LIQUID CROMATOGRAPHIC METHOD FOR THE ANALYSIS OF ZAFIRLUKAST IN A PHARMACEUTICAL FORMULATION 73
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 73
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 73
Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design 72
Diastereo-enantioseparation of novel gamma-lactamic derivatives on cellulose chiral stationary phases 72
Dosaggio HPLC della roxatidina, prove di stabilità e rilascio da formulazioni farmaceutiche. 72
MODELLO DI INTERAZIONE SELECTORS-SELCTANDS NEL PROCESSO DI DISCRIMINAZIONE CHIRALE. 72
Gemcitabine anticancer activity enhancement by water soluble celecoxib/ sulfobutyl ether-β-cyclodextrin inclusion complex 72
STRUCTURAL AND THERMODYNAMIC STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEXES 71
Study of the inclusion complex of atenolol with beta- cyclodextrins 71
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 71
Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin 71
PHARMACEUTICAL APPLICATION OF BETA-CYCLODEXTRIN: INCLUSION COMPLEXES WITH BETA-BLOCKERS 71
HYDRATATION EFFECT ON THE MICELLAR STRUCTURE OF TRI-BLOCK COPOLYMER IN WATER (VISCOELASTIC RESULTS). 71
Totale 9.446
Categoria #
all - tutte 50.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021762 0 0 0 0 24 139 8 136 34 110 129 182
2021/20221.116 26 203 16 31 20 2 86 50 5 127 207 343
2022/20232.942 221 213 141 203 266 280 62 172 1.244 17 98 25
2023/2024547 76 105 52 66 53 116 12 21 0 15 2 29
2024/20253.041 48 51 59 192 113 67 40 694 756 187 283 551
2025/20262.351 426 487 579 631 228 0 0 0 0 0 0 0
Totale 13.521